Intrinsic Validity of Molecular Marker(s) Detection on Tissular Tumoral DNA to Predict the Efficacy of 177Lutetium-PSMA-617 (Lu-PSMA) Treatment for Castration-resistant Metastatic Prostate Cancer
Clinical trial NCT06600802 · RECRUITING
Trial details
- NCT number
- NCT06600802
- Sponsor
- Centre Jean Perrin
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-08
- Primary completion
- 2034-06-30
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.